News & Events

Tissue Genesis Receives NASA Ames Team Honor Award (September 2010) Tissue Genesis Receives Joint Repair Grant from DOD (July 2010) Tissue Genesis Support of Space Experiments May Aid Eqrthly Ailments (April 2010) Tissue Genesis Support of Space Tissue Loss Experiments (March 2010) American Medical Systems and Tissue Genesis Sign $1.1 Million Collaboration Deal (January 2010) Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes (November 2009) Helping People Heal Themselves (October 2009) Bioheart Makes Breaktrhough in Cardiovascular Therapy (September 2009) Liposuction Excess Easily Converted to IPS Cells, Stanford Study Shows (September 2009) Liposuction Fat Turns to Stem Cells Quicker than Skin in Study (September 2009) Adult Stem Cells May Help Treat Multiple Sclerosis (April 2009) Tissue Genesis Featured in 2008 TATRC Annual Report(March 2009) Hope in Stem Cell Therapy (February / March 2009) Tissue Genesis Awarded $3.62 Million Military Ciontract (February 2009) Hawaii's Governor Lingel Presents Innovation Award to Tissue Genesis (December 2008) Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System (November 2008) Oahu Television KHNL8 News Story on the Women Scientist of Tissue Genesis (October 2008) Oahu Television KHON2 News Story on Tissue Genesis (May 2008) New Victories for Adult Stem Cell Research (Feb 2008) Tissue Genesis signs Exclusive Distribution and License Agreement with SpineSmith (October 2007) Isle biotech research heads for new heights... (May 2007)Tissue Genesis names Gentzkow chief medical officer...(Apr 2007) Howard Dicus interview of CEO Anton Krucky on PBS Hawaii (Jan 2007) Bioheart, Inc. announced today that it has acquired an option to the worldwide exclusive rights to Tissue Genesis, Inc.'s adipose (fat) derived therapeutic cell technology (Aug 2006) Biotech venture poised for success (Aug 2003) )Island Son Returns to Lead Emerging Bio-Tech Company (Jan/Feb 2003) Biotech embarks on lucrative federal project (March 2002)